Analyse
Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation
#US market entry ×
Analyse
1 sept. 2026•1 min de lecture
HK Innoen's K‑Cap (Tegoprazan) Targets US Launch, Boosts Growth Prospects
Domestic drug K‑Cap (tegoprazan) is nearing US market entry, with analysts seeing royalty revenue and a shift to global growth for HK Innoen.
Analyse
30 août 2026•1 min de lecture
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.